Photo-thermal therapy of bladder cancer with Anti-EGFR antibody conjugated gold nanoparticles

Chieh Hsiao Chen, Yi Jhen Wu, Jia Jin Chen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The aim of this study was to enhance the effectiveness of photo thermal therapy (PTT) in the targeting of superficial bladder cancers using a green light laser in conjunction with gold nanoparticles (GNPs) conjugated to antibody fragments (anti-EGFR). GNPs conjugated with anti-EGFR-antibody fragments were used as probes in the targeting of tumor cells and then exposed to a green laser (532nm), resulting in the production of sufficient thermal energy to kill urothelial carcinomas both in vitro and in vivo. Nanoparticles conjugated with antibody fragments are capable of damaging cancer cells even at relatively very low energy levels, while non-conjugated nanoparticles would require an energy level of 3 times under the same conditions. The lower energy required by the nanoparticles allows this method to destroy cancerous cells while preserving normal cells when applied in vivo. Nanoparticles conjugated with antibody fragments (anti-EGFR) require less than half the energy of non-conjugated nanoparticles to kill cancer cells. In an orthotopic bladder cancer model, the group treated using PTT presented significant differences in tumor development.

Original languageEnglish
Pages (from-to)1211-1221
Number of pages11
JournalFrontiers in Bioscience - Landmark
Volume21
Issue number6
DOIs
Publication statusPublished - 2016 Jun 1

Fingerprint

Urinary Bladder Neoplasms
Gold
Nanoparticles
Anti-Idiotypic Antibodies
Hot Temperature
Immunoglobulin Fragments
Antibodies
Cells
Electron energy levels
Therapeutics
Tumors
Neoplasms
Lasers
Methyl Green
Thermal energy
Carcinoma

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

@article{7fb54223423b4aa28793c38f9206668d,
title = "Photo-thermal therapy of bladder cancer with Anti-EGFR antibody conjugated gold nanoparticles",
abstract = "The aim of this study was to enhance the effectiveness of photo thermal therapy (PTT) in the targeting of superficial bladder cancers using a green light laser in conjunction with gold nanoparticles (GNPs) conjugated to antibody fragments (anti-EGFR). GNPs conjugated with anti-EGFR-antibody fragments were used as probes in the targeting of tumor cells and then exposed to a green laser (532nm), resulting in the production of sufficient thermal energy to kill urothelial carcinomas both in vitro and in vivo. Nanoparticles conjugated with antibody fragments are capable of damaging cancer cells even at relatively very low energy levels, while non-conjugated nanoparticles would require an energy level of 3 times under the same conditions. The lower energy required by the nanoparticles allows this method to destroy cancerous cells while preserving normal cells when applied in vivo. Nanoparticles conjugated with antibody fragments (anti-EGFR) require less than half the energy of non-conjugated nanoparticles to kill cancer cells. In an orthotopic bladder cancer model, the group treated using PTT presented significant differences in tumor development.",
author = "Chen, {Chieh Hsiao} and Wu, {Yi Jhen} and Chen, {Jia Jin}",
year = "2016",
month = "6",
day = "1",
doi = "10.2741/4451",
language = "English",
volume = "21",
pages = "1211--1221",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "6",

}

Photo-thermal therapy of bladder cancer with Anti-EGFR antibody conjugated gold nanoparticles. / Chen, Chieh Hsiao; Wu, Yi Jhen; Chen, Jia Jin.

In: Frontiers in Bioscience - Landmark, Vol. 21, No. 6, 01.06.2016, p. 1211-1221.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Photo-thermal therapy of bladder cancer with Anti-EGFR antibody conjugated gold nanoparticles

AU - Chen, Chieh Hsiao

AU - Wu, Yi Jhen

AU - Chen, Jia Jin

PY - 2016/6/1

Y1 - 2016/6/1

N2 - The aim of this study was to enhance the effectiveness of photo thermal therapy (PTT) in the targeting of superficial bladder cancers using a green light laser in conjunction with gold nanoparticles (GNPs) conjugated to antibody fragments (anti-EGFR). GNPs conjugated with anti-EGFR-antibody fragments were used as probes in the targeting of tumor cells and then exposed to a green laser (532nm), resulting in the production of sufficient thermal energy to kill urothelial carcinomas both in vitro and in vivo. Nanoparticles conjugated with antibody fragments are capable of damaging cancer cells even at relatively very low energy levels, while non-conjugated nanoparticles would require an energy level of 3 times under the same conditions. The lower energy required by the nanoparticles allows this method to destroy cancerous cells while preserving normal cells when applied in vivo. Nanoparticles conjugated with antibody fragments (anti-EGFR) require less than half the energy of non-conjugated nanoparticles to kill cancer cells. In an orthotopic bladder cancer model, the group treated using PTT presented significant differences in tumor development.

AB - The aim of this study was to enhance the effectiveness of photo thermal therapy (PTT) in the targeting of superficial bladder cancers using a green light laser in conjunction with gold nanoparticles (GNPs) conjugated to antibody fragments (anti-EGFR). GNPs conjugated with anti-EGFR-antibody fragments were used as probes in the targeting of tumor cells and then exposed to a green laser (532nm), resulting in the production of sufficient thermal energy to kill urothelial carcinomas both in vitro and in vivo. Nanoparticles conjugated with antibody fragments are capable of damaging cancer cells even at relatively very low energy levels, while non-conjugated nanoparticles would require an energy level of 3 times under the same conditions. The lower energy required by the nanoparticles allows this method to destroy cancerous cells while preserving normal cells when applied in vivo. Nanoparticles conjugated with antibody fragments (anti-EGFR) require less than half the energy of non-conjugated nanoparticles to kill cancer cells. In an orthotopic bladder cancer model, the group treated using PTT presented significant differences in tumor development.

UR - http://www.scopus.com/inward/record.url?scp=85016165406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016165406&partnerID=8YFLogxK

U2 - 10.2741/4451

DO - 10.2741/4451

M3 - Article

C2 - 27100501

AN - SCOPUS:85016165406

VL - 21

SP - 1211

EP - 1221

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 6

ER -